COVID-19 Vaccine Development Tools Market Analysis Report By Technology, By Application, By End Use And Segment Forecasts From 2021 To 2028

Synopsis

The global COVID-19 vaccine development tools market was prized by USD 16.0 billion in 2020. It is estimated to witness an 8.6% CAGR from 2021 to 2028.

Drivers

The market for COVID-19 vaccine development tools is likely to uphold its impetus, during the near future. It is credited to the global arrival of the developers as well as the manufacturing companies of vaccines. Despite the quick development as well as rolling out of the vaccines, mainly in the developed nations, the infectivity curve of SARS-CoV-2 presently has started to the area of little variation.

Moreover, the variation of SARS-CoV-2 has come out in 2020, that requires reinvestigation of the vaccination effectiveness for the first-generation vaccines, whereas present efforts are, even now, aimed towards the discovery of the finest method of the vaccine rollout, which deal with the exceptional vaccination plans, executed everywhere in the world.

Several things are adding to the enlargement of this business, together with, the essential function of artificial intelligence in the competition of COVID-19 vaccine, an increasing team of alliance to speeding up the research of vaccine along with the clinical trials, in addition to strong financial support by the private as well as government institutions. The current situation of speeding up the research of vaccines and clinical trials has supported the partnerships between manufacturing companies and vaccine developers.

To transform and make easy the development of novel COVID-19 vaccines, Artificial Intelligence (AI) possesses huge capability. Artificial Intelligence (AI) is expected to turn into essential growth of the shots for rising variants of coronavirus; the units working in this marketplace are associating with developers of the vaccine. This is, additionally, booming the market for COVID-19 vaccine development tools.

Application Insight

The vaccine research sector held the major, 43.9% revenue share and led the COVID-19 vaccine development tools market, in 2020. The enlargement of the sector is powered by several factors like rising policy for the business development by major pharmaceutical manufacturing companies, growing financial support by the government, and wide-ranging research by healthcare institutes plus the universities, among others. Likewise, the expansion of the sector can be, more, credited to incessant research actions for advancing the procedure of vaccine development.

Technology Insight

The laboratory technologies section held the major, 95.3% revenue share and led the COVID-19 vaccine development tool market, in 2020. Expanding practice of the laboratory technologies, like spectrometry, cell culture, flow cytometry, and PCR in the research & development of vaccines is estimated to add to the domination of the segment, during the forecast period.

In 2020, qPCR and PCR presented the maximum revenue input to the laboratory technologies section. Regular usage of PCR tools in vaccine inspection courses and testing of the effectiveness is credited to the expansion of the section. Online technologies are engaged to develop by a fast speed of 13.2% CAGR, throughout the forecast period.

End-Use Insight

In 2020, the Pharma & Biopharma companies sector held the biggest; more than 42.0% revenue share, and led the COVID-19 vaccine development tools market. Due to their presented infrastructure of vaccine development, these companies were among the first important participants in researching SARS-CoV-2, in the initial phases of the pandemic.

The strong investment ability of the pharmaceutical manufacturing companies, for making it possible the fast advancement of the COVID-19 vaccine, can be credited to the major share of the sector.

Large-scale pharmaceutical manufacturing companies are working together with biotech companies for supporting them in increasing the production procedure of the COVID-19 vaccine.

Mostly, the research institutes are concentrating on carrying out the research analysis, meant for getting new resolutions, which can be applied in the development process of a vaccine. They are developing several online tools as well as scrutinizing the data derived from them, which can be utilized for speedy vaccine improvement.

Regional Insight

In 2020, Asia Pacific held the biggest 39.6% revenue share and led the market for COVID-19 vaccine development tools. The detection of the new corona virus’ genome, in the early hours, by way of utilizing highly developed sequencing techniques, within the region, was the most important factor that added to the speeding up the development of a vaccine for the SARS-CoV-2.

The Chinese researchers performed several investigations, aimed at before time genome sequencing, the study of viral structure, along with resistant reaction report by way of the corresponding use of advanced sequencing, flow cytometry, and electron microscopy.

North America held a 28.0% revenue share of the global market, in 2020. The regional enlargement can be credited to several factors like increasing cases of COVID-19, huge residents base getting COVID-19 vaccine, rising R&D actions, plans for the financial support, the existence of major companies, and others.

Besides, the encouraging government schemes, intended for developing vaccines for COVID-19, can be extra credited to the enlargement of the market. Such as, the U.S. government introduced Operation Warp Speed. It is the public-private joint venture for the improvement, production, and delivery of COVID-19 vaccines.

Companies

The companies are concentrating on the enlargement of their contributions, by way of wide-ranging R&D, along with the creation of the joint venture and associations with additional major companies, to maintain their place in the market.

Some of the companies for the COVID-19 vaccine development tools market are:

    • Aurora Biomed Inc.
    • Polyplus Transfection
    • OLYMPUS CORPORATION
    • PerkinElmer Inc.
    • Charles River Laboratories
    • Shimadzu Corporation
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • STEMCELL Technologies Inc.
    • Pfizer Inc.
    • Celerion
    • Hamilton Company
    • Avantor, Inc.
    • Fluidigm
    • Takara Bio Inc.
    • Euro fins Scientific
    • Qiagen N.V.
    • Danaher
    • Agilent Technologies
    • AB Sciex Pte. Ltd.
    • Sartorius AG
    • Cole-Parmer Instrument Company, LLC.
    • Thermo Fisher Scientific, Inc.

 Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2028. For this study, Million Insights has segmented the global COVID-19 vaccine development tools market report based on technology, application, end-use, and region:

• Technology Outlook (Revenue, USD Million, 2020 - 2028)
    • Laboratory Technologies
        • Next Generation Sequencing
        • PCR & qPCR
        • Flow Cytometry
        • Spectrometry
        • Microscopy & Electron Microscopy
        • Preparative & Process Chromatography
        • Nucleic Acid Isolation & Purification
        • Transfection Electroporation
        • Cell Culture
        • Automated Liquid Handling
    • Online Technologies
        • Interactive Web Technologies
        • Vaccine Management & Tracker Technologies

• Application Outlook (Revenue, USD Million, 2020 - 2028)
    • Vaccine Research
    • Vaccine Process Development
    • Vaccine Quality Assurance/Quality Control
    • End-use Outlook (Revenue, USD Million, 2020 - 2028)
    • Pharma & Biopharma Companies
    • Contract Research Organization (CROs)
    • Academic & Research Institutes

• Regional Outlook (Revenue, USD Million, 2020 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • U.K.
        • Italy
        • France
        • Spain
        • Russia
    • Asia Pacific
        • China
        • India
        • South Korea
        • Australia
        • Japan
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa
        • Saudi Arabia